Retrospective studies have shown that combinations of the Model of End Stage Liver Disease (MELD)c score, Milan Criteria, and alpha fetoprotein (AFP) biomarker levels at diagnosis can be used to stratify an ideal bridge to LT candidates [3]. The gene discussed is AFP; the disease is End Stage Liver Disease.